Post treatment echocardiagraphic parameters. by Sophie Constantin Lütken (689916)

Subjects:

AQP2 and p-AQP2 abundance. by Sophie Constantin Lütken (689916)

Subjects:

Inner medullary expression of AQP1. by Sophie Constantin Lütken (689916)

Subjects:

Gsα subunit abundance. by Sophie Constantin Lütken (689916)

Subjects:

Cell Substratum Adhesion during Early Development of <i>Dictyostelium discoideum</i> by Marco Tarantola (102609)

Subjects:

Pretreatment echocardiagraphic parameters. by Sophie Constantin Lütken (689916)

Subjects:

Inner medullary expression of the (pro)renin receptor. by Sophie Constantin Lütken (689916)

Subjects:

Diagram of study design. by Sophie Constantin Lütken (689916)

Subjects:

Type 1_A angiotensin II receptor abundance. by Sophie Constantin Lütken (689916)

Subjects:

Substratum adhesion in cells lacking <i>sibA</i> or s<i>adA</i>. by Marco Tarantola (102609)

Subjects:

Inner medullary expression of AQP4. by Sophie Constantin Lütken (689916)

Subjects:

Changes in renal function. by Sophie Constantin Lütken (689916)

Subjects:

V2 vasopressin receptor abundance. by Sophie Constantin Lütken (689916)

Subjects:

Inner medullary expression of the type 1_A angiotensin II receptor. by Sophie Constantin Lütken (689916)

Subjects:

Effects of anchor-away depletion of Esa1, Gcn5 and Esa1/Gcn5 together. by Xue Cheng (6400607)

“…Esa1 depletion shows rapid loss of H4ac (penta) while Gcn5 depletion shows a decrease of H3ac, most notably H3K27ac. <b>B)</b> Percentage of HO cutting efficiency in No-FRB, FRB-Esa1, Gcn5-FRB and FRB-Esa1/Gcn5-FRB strains after 30min of induction in galactose. …”

Images and quantitative results from bone fragment evaluation. by Marsel Ganeyev (21453399)

Impact of Advanced Hybrid Closed-Loop on Youth with High-Risk Type 1 Diabetes Using Multiple Daily Injections by Alisa Boucsein (14305409)

“…</p> <p>Research Design and Methods: This prospective 3-month single-arm, dual-center study enrolled 20 participants, and all completed the study. </p> <p>Results: HbA1c decreased from 10.5 ± 2.1% (91.2 ± 22.8 mmol/mol) at baseline to 7.6 ± 1.1% (59.7 ± 11.9 mmol/mol) and time spent in target range 70–180 mg/dL (3.9–10.0 mmol/L) increased from 27.6 ± 13.2% at baseline, to 66.5 ± 9.8% after 3 months of AHCL. …”

MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment by Wei-Hong Kuang (5255186)

“…Eight weeks after antidepressant treatment, the patients exhibited increased miRNA-451a levels, decreased miRNA-34a-5p and miRNA-221-3p levels, and reduced HAMD scores. …”

Transitioning of people with T1D from Multiple Daily Injections (MDI) and Self-Monitoring of Blood Glucose (BGM) directly to MiniMed™ 780G Advanced Hybrid Closed Loop (AHCL) system... by Bartłomiej Matejko (13180606)

“…</p> <p>Research Design and Methods: The trial was a two-center, randomized controlled, parallel group study evaluating individuals with T1DM aged 26-60 years managed with Multiple Daily Injection (MDI) and self-monitoring of blood glucose (BGM), with an HbA1c <10%. …”

Unadjusted mean (SD) volume (ml) of beer sold per day, overall and by serving size, and volume of wine (ml) sold of premises included in primary analysis (<i>n</i> = 12). by Eleni Mantzari (6991172)

Subjects: